Offer - Urjas Oil for just ₹ 1
Glybovin 1.25 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Diabetes Type 2. Secondary and off-label uses of Glybovin 1.25 Tablet have also been mentioned below.
The optimal dosage of Glybovin 1.25 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Glybovin 1.25 Tablet can also lead to other problems, which have been listed below. These side effects of Glybovin 1.25 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Glybovin 1.25 Tablet's effect during pregnancy is Severe and Severe while nursing. Further, the section on Glybovin 1.25 Tablet related warnings talks about Glybovin 1.25 Tablet's effects on the liver, heart and kidney.
Glybovin 1.25 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Kidney Disease, Heart Disease are examples of such conditions. The section on Glybovin 1.25 Tablet contraindications lists all such conditions.
Drug interactions for Glybovin 1.25 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Glybovin 1.25 Tablet is safe while driving, and is addiction.
Glybovin 1.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Glybovin 1.25 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Glybovin. If you are pregnant, do not take Glybovin without a doctor's advice.
Is the use of Glybovin 1.25 Tablet safe during breastfeeding?
Taking Glybovin may lead to serious side effects if you are breastfeeding. Glybovin should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Glybovin 1.25 Tablet on the Kidneys?
Glybovin may have severe effects on your kidney, so do not take it without consulting your doctor.
What is the effect of Glybovin 1.25 Tablet on the Liver?
Glybovin may have severe effects on your liver, so do not take it without first consulting your doctor.
What is the effect of Glybovin 1.25 Tablet on the Heart?
Glybovin has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Glybovin 1.25 Tablet unless your doctor advises you to do so -
Is this Glybovin 1.25 Tablet habit forming or addictive?
No, you will not get addicted to Glybovin 1.25 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Glybovin 1.25 Tablet since it does not cause drowsiness.
Is it safe?
Yes, Glybovin 1.25 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Glybovin 1.25 Tablet is not used to treat mental disorders.
Interaction between Food and Glybovin 1.25 Tablet
Due to the absence of research, it is difficult to say how Glybovin 1.25 Tablet and food will interact.
Interaction between Alcohol and Glybovin 1.25 Tablet
Consult your doctor before consuming alcohol while taking Glybovin 1.25 Tablet as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glynase® PresTab® (micronized glyburide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272